Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model 2021-08-05 18:00
Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol® 2021-08-03 21:00
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China 2021-08-03 20:00
TCM Lianhua Qingwen shows stable in vitro antiviral effect on the Delta variant: Expert 2021-08-03 15:27
Bionomics Announces Plans to Conduct U.S. Initial Public Offering 2021-08-02 18:00
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic 2021-08-02 11:11
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report 2021-07-30 21:05
China Jo-Jo Drugstores Completes Redomiciliation Merger 2021-07-30 21:00
I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease 2021-07-30 20:00
I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company up to US$40 Million 2021-07-29 20:00
HanAll Biopharma Reports Second Quarter 2021 Results 2021-07-29 18:44
Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial 2021-07-29 18:00
Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial 2021-07-28 21:08
I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-07-28 19:15
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China 2021-07-28 13:47
I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange 2021-07-27 20:35
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference 2021-07-26 20:00
HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021 2021-07-26 19:11
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day 2021-07-21 22:00
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy 2021-07-20 20:00
1 82 83 84 85 86 147